Stay updated on Vudalimab for Anaplastic/Hurthle Thyroid Cancer Clinical Trial
Sign up to get notified when there's something new on the Vudalimab for Anaplastic/Hurthle Thyroid Cancer Clinical Trial page.

Latest updates to the Vudalimab for Anaplastic/Hurthle Thyroid Cancer Clinical Trial page
- Check4 days agoChange DetectedA new revision entry v3.4.3 is added to the record history, replacing the previous v3.4.2 entry.SummaryDifference0.1%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check32 days agoChange DetectedRevision: v3.4.2 added and a prior site-wide notice about funding (v3.4.1) removed. These updates are administrative and do not affect the study record content or essential navigation. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.9%

- Check39 days agoChange DetectedAdded a site-wide government funding notice and updated operating-status information (cc.nih.gov and opm.gov). The history now shows Revision: v3.4.1, replacing v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.9%

- Check46 days agoChange DetectedThe new version adds a 'Show glossary' option and a revision note dated 2025-10-20, with color-coded additions (green) and deletions (red) explained for the study record changes.SummaryDifference1%

- Check82 days agoChange DetectedRevision: v3.3.3 was added to the Record History; HHS Vulnerability Disclosure and Revision: v3.3.2 were removed.SummaryDifference0.2%

- Check104 days agoChange DetectedRevision history now includes v3.3.2 and removes v3.3.1.SummaryDifference0.1%

Stay in the know with updates to Vudalimab for Anaplastic/Hurthle Thyroid Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Vudalimab for Anaplastic/Hurthle Thyroid Cancer Clinical Trial page.